#biosimilars (2 Posts)
-
Daewoong's Bold Move: Entering the $185 Billion Biosimilar Market Daewoong Pharmaceutical will launch a biosimilar business to seek new growth opportunities under the leadership of Hong Seung-suh. -
Celltrion Launches Affordable Biosimilars in the U.S. Market: A Game Changer for Patients! Celltrion launches denosumab biosimilars Stoboclo and Osenvelt in the US market, tapping into a $6.5 billion opportunity.
Hot Topics